Literature DB >> 2829208

Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism.

L H Block1, M Knorr, E Vogt, R Locher, W Vetter, P Groscurth, B Y Qiao, D Pometta, R James, M Regenass.   

Abstract

Low density lipoprotein (LDL), at concentrations high enough for receptor binding but not high enough to saturate the receptor, induces activation of phosphatidylinositol (PtdIns) turnover in a variety of cell types with various biological functions. Using both biochemical and electron microscopic studies, we have shown that blood platelets take up and degrade LDL in a manner reminiscent of phagocytic cell types. The activation of both PtdIns turnover and LDL metabolism is inhibited by high density lipoprotein. Thus, LDL at hormonal concentrations causes general cellular activation. Since all cell types studied responded to LDL with increased PtdIns turnover and uptake of LDL cholesterol, the PtdIns cycle may also be involved in the cellular regulation of LDL cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829208      PMCID: PMC279661          DOI: 10.1073/pnas.85.3.885

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

3.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

4.  Uptake of latex particles by blood platelets: phagocytosis or sequestration?

Authors:  J G White
Journal:  Am J Pathol       Date:  1972-12       Impact factor: 4.307

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Low density lipoprotein binding, internalization, and degradation in human adipose cells.

Authors:  A Angel; M A D'Costa; R Yuen
Journal:  Can J Biochem       Date:  1979-06

7.  Production of diglyceride from phosphatidylinositol in activated human platelets.

Authors:  S Rittenhouse-Simmons
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Platelet lipid composition and platelet aggregation in human liver disease.

Authors:  J S Owen; R A Hutton; R C Day; K R Bruckdorfer; N McIntyre
Journal:  J Lipid Res       Date:  1981-03       Impact factor: 5.922

9.  Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.

Authors:  S J Shattil; J S Bennett; R W Colman; R A Cooper
Journal:  J Lab Clin Med       Date:  1977-02

10.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

View more
  18 in total

1.  Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function.

Authors:  A W Hahn; T J Resink; T Scott-Burden; J Powell; Y Dohi; F R Bühler
Journal:  Cell Regul       Date:  1990-08

Review 2.  Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae.

Authors:  M L Greenberg; J M Lopes
Journal:  Microbiol Rev       Date:  1996-03

3.  Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique.

Authors:  V N Bochkov; V A Tkachuk; M P Philippova; D V Stambolsky; F R Bühler; T J Resink
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

4.  Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.

Authors:  R D Bigler; M Khoo; S Lund-Katz; L Scerbo; M Esfahani
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.

Authors:  S Allen; S Khan; F Al-Mohanna; P Batten; M Yacoub
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin.

Authors:  K Rubina; E Talovskaya; V Cherenkov; D Ivanov; D Stambolsky; T Storozhevykh; V Pinelis; A Shevelev; Ye Parfyonova; T Resink; P Erne; V Tkachuk
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

7.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells.

Authors:  T A Voyno-Yasenetskaya; L G Dobbs; S K Erickson; R L Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction.

Authors:  C P Tensen; E R Van Kesteren; R J Planta; K J Cox; J F Burke; H van Heerikhuizen; E Vreugdenhil
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Effect of ethanol on low density lipoprotein and platelet composition.

Authors:  J L Hojnacki; J E Cluette-Brown; R N Deschenes; J J Mulligan; T V Osmolski; N J Rencricca; J J Barboriak; J A Jakubowski
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.